Search

everythinglearnresearchcommunity

for

Search:↓

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

CS12192 effectively treats alopecia areata with better safety than current options.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Redensyl, saw palmetto, and biotin with platelet-rich plasma is a better treatment for hair loss than Procapil with platelet-rich plasma.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Both Minoxidil and PRP are effective for male pattern baldness treatment.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Tailored medication preparation and ongoing education are crucial for effective treatments.

The lotion with equol, dihomo-γ-linolenic acid, and propionyl-l-carnitine was effective in reducing hair loss in men and women.

Topical Ruxolitinib may safely treat severe hair loss.

New compounds may help treat prostate issues without affecting androgen receptors.

Certain medications, especially nervous system drugs, can cause insomnia, with risks varying by age and gender.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

An arthritis drug helped a person with severe hair loss regrow their hair.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.